ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,870.62
0.00%
US Tech 100
19,910.40
0.24%
Dow Jones
43,444.99
0.00%
Brent Oil
71.50
1.12%
Bitcoin
89,581.19
-0.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zymeworks Inc (ZYME) Quote

Zymeworks Inc

Zymeworks Inc (ZYME)

NASDAQ
15.39
-0.87
(-5.35%)
Closed November 15 4:00PM
Delayed by 15 minutes
15.39
0.00
( 0.00% )
Pre Market: 7:00AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
15.39
Bid
14.00
Ask
16.86
Volume
6
0.00 Day's Range 0.00
7.97 52 Week Range 17.70
Market Cap
1.06B
Previous Close
15.39
Open
-
Last Trade
1
@
15.38
Last Trade Time
08:38:55
Financial Volume
-
VWAP
-
Average Volume (3m)
605,436
Shares Outstanding
68,877,526
Dividend Yield
-
PE Ratio
-3.73
Earnings Per Share (EPS)
-1.72
Revenue
76.3M
Net Profit
-118.67M

About Zymeworks Inc

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.zymeworks.com
Headquarters
North Vancouver, British Columbia, Can
Founded
-
Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZYME. The last closing price for Zymeworks was $15.39. Over the last year, Zymeworks shares have traded in a share price range of $ 7.97 to $ 17.70.

Zymeworks currently has 68,877,526 shares outstanding. The market capitalization of Zymeworks is $1.06 billion. Zymeworks has a price to earnings ratio (PE ratio) of -3.73.

Ask ADVFN Intelligence (AI)

ZYME Latest News

More News

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

VANCOUVER, British Columbia, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

November 05 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

October 31 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 31 2024
Edgar (US Regulatory)

Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results

First patient dosed in Phase 1 clinical trial evaluating ZW171 in advanced mesothelin (MSLN)-expressing cancers Preclinical data presented on ZW220 and ZW251 at EORTC-NCI-AACR conferenceOur...

October 31 2024
GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders

October 29 2024
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

October 29 2024
Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements

October 29 2024
Edgar (US Regulatory)

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

October 29 2024
GlobeNewswire Inc.

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Presentations highlight key preclinical data that support investigational new drug application (IND) submissions for ZW220 in 1H and ZW251 in 2H in 2025 VANCOUVER, British Columbia, Oct. 25...

October 25 2024
GlobeNewswire Inc.

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other mesothelin (MSLN) expressing cancers...

October 21 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.37-8.1742243436816.7617.714.4254864316.65276373CS
41.9914.850746268713.417.712.3956684814.90210207CS
123.8933.826086956511.517.711.1860543613.17157954CS
266.369.30693069319.0917.78.2163826411.20012083CS
527.287.91208791218.1917.77.9760016610.69783473CS
1569.01141.2225705336.3817.76.0156294349.42853457CS
2609.01141.2225705336.3817.76.0156294349.42853457CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HCWBHCW Biologics Inc
$ 0.9607
(226.10%)
50.03M
APLMApollomics Inc
$ 0.2008
(109.38%)
163.5M
NIVFNewGenIvf Group Ltd
$ 1.07
(64.36%)
24.2M
SINTSiNtx Technologies Inc
$ 3.15
(54.41%)
15.49M
HONEHarborOne Bancorp Inc
$ 19.00
(44.93%)
173
CMAXCareMax Inc
$ 0.89
(-47.02%)
101.23k
HURCHurco Companies Inc
$ 12.01
(-44.01%)
2
LYTSLSI Industries Inc
$ 12.01
(-40.16%)
108
NGNENeurogene Inc
$ 23.05
(-33.22%)
52.44k
JOUTJohnson Outdoors Inc
$ 22.01
(-33.16%)
1
APLMApollomics Inc
$ 0.2025
(111.16%)
163.66M
HCWBHCW Biologics Inc
$ 0.9711
(229.63%)
50.08M
ELABElevai Labs Inc
$ 0.0231
(4.52%)
36.16M
NIVFNewGenIvf Group Ltd
$ 1.07
(64.36%)
24.2M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 20.77
(11.01%)
23.03M

Discussion

View Full Feed
budfoxfun budfoxfun 4 minutes ago
John Schultz, Director of Revenue and Operations at SGTM, expressed his enthusiasm about this accomplishment, stating, "This remarkable achievement marks a significant moment in our journey to convert biomass into reusable products. It demonstrates our commitment to safeguarding the environment and
SGTM
WebSlinger WebSlinger 5 minutes ago
The Scumbag CEO has lied for 15+ years about everything under the sun, yet now we are supposed to believe him? LOL

Please show us a photo of the gloves (and I mean a photo where someone can recognize that it is actually a glove). You can't, because the Scumbag CEO never released one
KBLB
Real McCoy Real McCoy 5 minutes ago
Absurd. I’d love to see how he thinks that could happen.
ANTI-BAGHOLDER ANTI-BAGHOLDER 5 minutes ago
MONI it only takes 3 seconds of DD to see what we are really dealing with. Here is one Government contract from NVIS below. Its just a matter of when here...

The federal contract IDV awarded to Nvis Communications, LLC is a Multiple Award Schedule (MAS) contract with the Genera
MONI
surfkast surfkast 6 minutes ago
Go to Remington Park and ask George. He is there daily now watching his horses.

https://www.equibase.com/profiles/Results.cfm?type=People&searchType=O&eID=2019898&rbt=TB

https://www.remingtonpark.com/calendar-posttimes/
WNFT
glenn1919 glenn1919 6 minutes ago
DDC.......NIVF......MULN......ZONE.............................https://www.stockscores.com/charts/charts/?ticker=ZONE
DDC MULN NIVF
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 minutes ago
MONI it only takes 3 seconds of DD to see what we are really dealing with. Here is one Government contract from NVIS below. Its just a matter of when here...

The federal contract IDV awarded to Nvis Communications, LLC is a Multiple Award Schedule (MAS) contract with the Genera
MONI
LowFloatLopes LowFloatLopes 7 minutes ago
Gonna be a fun week here 
AZRH
glenn1919 glenn1919 7 minutes ago
GOVX......HCWB.....APLM.....MNDR.......https://www.stockscores.com/charts/charts/?ticker=GOVX
APLM GOVX HCWB
docsetc docsetc 7 minutes ago
The recovery is posted against Adnexus Biotech in this legal matter, and there are 3-4 ways to recover what as lost.

That's all I can say at present. ENZC is about to be buried forever by the SEC action. Chandra watches this board, and we're not spotting him any more info.
ENZC
Bountiful_Harvest Bountiful_Harvest 7 minutes ago
I believe you're correct. Kakashii@kakashiii111 Oct 3, 2024
Nvidia failed to disclose that Blackwell suffered from a design defect that adversely impacted yields. This issue was only discovered later when clients reported delays in their shipments. In response, Jensen urgently addressed the p
NVDA
resx18 resx18 7 minutes ago
Halted .. #BK $SAVE
SAVE
Gnarlyman Gnarlyman 7 minutes ago
Job Mobs (Recruiter.com) bought another business to add to their stable. 

CognoGroup's equity stake just keeps getting better. Plus, they technology sharing should bring in decent revenue if utilized by all of Tinsley's subs. 

AESO
ShawnP123 ShawnP123 7 minutes ago
Not down because of a typical trend. It's down for a reason. I have a feeling the traders knew about the thermal issue last week when we had the sell off. Based on the pre-market high volume this is going to be another sell off.
NVDA
weedtrader420 weedtrader420 7 minutes ago
ELON said XRP D.O.G.E 🪲🪲STAND BY ME $1.47 TARGET today
XRPUSD
SCHH SCHH 8 minutes ago
CORRECTION UP 8% .6020
ELTP
jxyzobrien jxyzobrien 8 minutes ago
this week
nvda news and election news and market has not started to price
in new economic policy.

so far normal up monday unless news bad news
I am looking to short and hold. but not till charts say soo

"EVIL ONLY WINS WHEN GOOD MEN WATCH AND DO N
tw0122 tw0122 8 minutes ago
Flip it now $4.40s had troubles with passing resistance zone right above last round 
UAVS
glenn1919 glenn1919 9 minutes ago
IMCC......PULM......IRIX.......ELAB.......https://www.stockscores.com/charts/charts/?ticker=PULM
ELAB IMCC IRIX
mahatmapaul mahatmapaul 9 minutes ago
That is the most damning document I have yet come across exposing parks absolutely fraudulent nature
SPZI
sonicty28 sonicty28 10 minutes ago
Hey, a fellow Celsius owner. I am a brother in misery, owned them at incredibly low prices and sold wayyy too early thinking they would never get off their feet. Hopefully KBLB makes up for that for us!
KBLB

Your Recent History

NASDAQ
ZYME
Zymeworks
NYSE
KREF-A
KKR Real Estate Finance
TG
A180VG
Unilever
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved